MECHANISM OF ACTION
The Growth Matrix stacks three growth hormone peptides that each do something slightly different. CJC-1295 provides the long-lasting foundation, keeping the pituitary primed to release growth hormone for days from a single dose. Ipamorelin adds precise, clean growth hormone pulses without raising stress hormones. Tesamorelin provides a daily growth hormone signal with a particular focus on visceral fat (the deep belly fat around organs), which is the mechanism it is best characterised for. Together, they cover three angles at once: a long-term baseline signal (CJC-1295), well-timed pulse quality (Ipamorelin), and targeted fat reduction (Tesamorelin).
RESEARCH APPLICATIONS
- Maximal physiological GH stimulation research
- Body composition - lean mass, visceral fat, and recovery
- Anti-ageing somatopause intervention models
- Cognitive function and GH/IGF-1 axis research
- Post-exercise recovery and anabolic support
RESEARCH HIGHLIGHTS
Triple GH-Axis Stimulation
Each component validated independently; the triple stack provides GHRH baseline (CJC-1295) + GHS-R pulse trigger (Ipamorelin) + daily GHRH reinforcement with visceral specificity (Tesamorelin).
Ref: See individual compound pages
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Reconstituted blend: 2–8°C, 21 days. Follow Tesamorelin storage (most sensitive component).
Regulatory Status
All components WADA S2 prohibited. Research compound. SA research import authorisation required.
Important - read before proceeding
This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.
Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.